PATENT CLAIM ANALYSIS

Application Number: 15917983
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-01
Patent Classification: ["514", "342000"]

Abstract:
The present application describes deuterium-enriched pioglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.

Claim (Index 1):
A method of treating diabetes mellitus type 2, comprising administering a therapeutically effective amount of a deuterium-enriched compound of formula I to a patient in need thereof to treat the diabetes mellitus type 2, wherein formula I is represented by: or pharmaceutically acceptable salt thereof, wherein R 1  and R 3 -R 20  are independently H or D.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.05
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15088472', '12233751', '15109533', '12205664', '12206368']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6946277437901223
- 35 USC 102 Novelty (BERT): 0.4883249734159594
- Combined Prediction Score: 0.673997466752706
- Mean Citation Score: 192.134502
- Max Citation Score: 210.25464
- Similarity Product: 165.24440946287154

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test